+1.62%

S&O 500 5,382.45

-0.47%

US 10 400

+2.28%

Nasdaq 16,565.41

+2.28%

Crude Oil 16,565.41

-0.27%

FTSE 100 8,144.87

+1.06%

Gold 2,458.10

-0.53%

Euro 1.09

+0.36%

Pound/Dollar 1.27

Sunday, November 8, 2026
Business News

Cabaletta Bio reports phase 1/2 data for autoimmune therapy

by marketdash
by marketdash 0 comments

Get New Updates nto Take Care Your Pet

Discover the art of creating a joyful and nurturing environment for your beloved pet.

Subscribe my Newsletter for new blog posts, tips & new photos. Let's stay updated!

Will be used in accordance with our Privacy Policy

Most read

Cabaletta Bio reports phase 1/2 data for autoimmune therapy
As AI trade tires, BCA calls for European stocks to beat Wall Street
Paul Gama, P&G CEO-health care, sells $477,510 in stock
Facebook Twitter Youtube Pinterest Instagram

@ 2024 – Marketdash – All Rights Reserved.

@2021 - All Right Reserved. Designed and Developed by PenciDesign